Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

79.600
-4.150-4.96%
Volume:9.18M
Turnover:721.74M
Market Cap:101.09B
PE:71.07
High:82.600
Open:81.900
Low:76.050
Close:83.750
52wk High:85.600
52wk Low:43.500
Shares:1.27B
HK Float Shares:1.27B
Volume Ratio:2.26
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.120
ROE:16.33%
ROA:9.32%
PB:7.63
PE(LYR):71.07
PS:12.41

Loading ...

Movement Alert|WUXI XDC Falls 4.24% in Regular Trading, Sector-Wide Pressure Weighs on Outsourcing Stocks

Market Focus
·
Yesterday

Movement Alert|WUXI XDC Rises 3.17% in Regular Trading, Driven by Buy Rating and FDA Inspection Milestone

Market Focus
·
Oct 12

WuXi XDC Cayman Inc.: Schroders Limited Disposes of Shares, Long Position Falls to 4.85%

HK Disclosure
·
Oct 09

Movement Alert|WUXI XDC Intraday Decline 3.47%, Life Sciences Tools & Services Sector Under Broad Pressure

Market Focus
·
Oct 09

Movement Alert|WUXI XDC Falls 3.38% in Regular Trading, Life Sciences Tools & Services Sector Under Broad Pressure

Market Focus
·
Oct 07

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Stock News
·
Oct 06

Movement Alert|WUXI XDC Rises 3.02% in Regular Trading, Trading at HK$83.65

Market Focus
·
Oct 06

Movement Alert|WUXI XDC Falls 3.66% in Regular Trading, Major Shareholder Reduction Overhang Persists Amid Broad Sector Weakness

Market Focus
·
Oct 02

WuXi XDC Shares In Focus After Singapore Plant Approval

Simply Wall St.
·
Oct 01

Goldman Sachs: Asian CDMOs Enter a Structural Growth Cycle, with Peptides, ADCs, Oligonucleotides, and AIDD as New Engines

Stock News
·
Sep 30

Movement Alert|WUXI XDC Rises 3.01% in Regular Trading, Sector Rebound Coupled with New Strategic Investment Expansion

Market Focus
·
Sep 30

Movement Alert|WUXI XDC Falls 3.34% in Regular Trading, Major Shareholder Reduction Ripple Effect Compounds Sector Weakness

Market Focus
·
Sep 29

Movement Alert|WUXI XDC Falls 3.02% in Regular Trading, Life Sciences Sector Under Broad Pressure Amid Lingering Shareholder Reduction Overhang

Market Focus
·
Sep 28

Goldman Sachs assigns Buy rating to Wuxi XDC with HK$97.90 target price

Deep News
·
Sep 27

Goldman Sachs: WuXi XDC's Commercial Manufacturing Validation Seen as Key Long-Term Visibility Catalyst

Stock News
·
Sep 25

China's Roadmap for Pharmaceuticals May Support Sector Development

Dow Jones
·
Sep 21

Movement Alert|WUXI XDC Rises 3.51% in Regular Trading, Morgan Stanley Reaffirms Overweight Rating with 85 HKD Target as Sector Rallies

Market Focus
·
Sep 21

Morgan Stanley Reiterates Overweight Call on WUXI XDC, Sets Target at HK$85

Deep News
·
Sep 20

WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics

Reuters
·
Sep 17

Movement Alert|WUXI XDC Rises 3.01% in Regular Trading, Schroders Increases Stake Past 5% Disclosure Threshold

Market Focus
·
Sep 17